FDA Gives Final Approval to Abuse-Deterrent Xtampza ERFDA Gives Final Approval to Abuse-Deterrent Xtampza ER
The approval of the abuse-deterrent oxycodone formulation follows 'tentative' approval last fall for management of chronic pain requiring daily, around-the-clock opioid treatment. FDA Approvals
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Neurology & Neurosurgery News Alert Source Type: news
More News: Brain | Chronic Pain | Neurology | Neurosurgery | Oxycodone | OxyContin | Pain | Pain Management | Surgery